XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating Activities:    
Net income $ 3,764 $ 2,297
Adjustments to reconcile net income to net cash used in operating activities    
Depreciation and amortization 1,175 688
Amortization of debt discount 541 101
Stock-based compensation 949 895
Shares issued for services 65 40
Gain on forgiveness of Paycheck Protection Program (1,552)
Gain on settlement of Seller Note (1,538)
Change in fair value of Convertible Loan (166)
Deferred tax provision
Allowance for doubtful accounts 106 (30)
Increase in notes due to in-kind interest 310
Loss on debt waiver consent 1,212
Loss on warrant amendment 345  
Loss on change in fair value of contingent consideration 73  
Gain on change in fair value of warrants (7,902)
(Gain)/loss on settlement of obligations 274 (103)
Changes to operating assets and liabilities:    
Accounts receivable and unbilled receivables (4,035) 443
Inventories (562) 283
Prepaid expenses and other current assets 184 (1,128)
Vendor deposits (995)
Operating lease right-of-use assets, net (699) 176
Other operating assets and liabilities, net 21 (7)
Accounts payable 2,487 (742)
Deferred revenue 1,178 247
Accrued expenses 229 (220)
Deposits 809 (173)
Operating lease liabilities, non-current 718 (184)
Net cash used in operating activities (63) (363)
Investing activities    
Purchases of property and equipment (32) (10)
Capitalization of internal and third-party labor for software development (2,328) (194)
Acquisition of business, net of cash acquired (17,186)
Net cash used in investing activities (19,546) (204)
Financing activities    
Principal payments on finance leases (4)
Proceeds from sale of common stock in PIPE, net of offering expenses 1,814
Proceeds from sale & exercise of pre-funded warrants in PIPE, net of offering expenses 8,295
Proceeds from Acquisition Loan, net of offering expenses 9,868
Repayment of Seller Note (411) (100)
Proceeds from sale of shares via registered direct offering, net 1,849
Net cash provided by financing activities 19,566 1,745
Increase/(decrease) in Cash and Cash Equivalents (43) 1,178
Cash and Cash Equivalents, beginning of period 2,883 1,826
Cash and Cash Equivalents, end of period $ 2,840 $ 3,004